日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting CDC42 Protects Mitochondrial Function through KLF2/HIF-1α/PINK1 Signaling in Acute Kidney Injury.

靶向 CDC42 通过 KLF2/HIF-1α/PINK1 信号通路保护急性肾损伤中的线粒体功能。

Zhou Xue, Fu Xian, Meng Yi-Wen, Dai Ping, Jiang Qing, Yin Hou-Hua, Pan Qing-Jin, Lin Ai-Zhi, Ni Kai-Di, Luo Zi-Guo, Liang Ru-Yu, Chen Yi-Yu, Yuan Hai-Xin, Liu Jun-Yan

KLF2 overrides the resident memory CD8 T cell differentiation program, in opposition to KLF3

与 KLF3 相反,KLF2 会抑制驻留记忆 CD8 T 细胞的分化程序。

DePauw, Taylor A; Gai, Kexin; Shen, Jian; Maurice, Nicholas J; Rhee, Ka Hyun; Valente, William J; O'Connor, Christine H; Cui, Weiguo; Peng, Changwei; Jameson, Stephen C

ScRNA-seq reveals dynamic macrophage heterogeneity in chronic liver disease progression and prognostic biomarkers KLF2/SPP1 in HCC

单细胞RNA测序揭示慢性肝病进展中巨噬细胞的动态异质性以及肝细胞癌中的预后生物标志物KLF2/SPP1

Pan, Qi; Wang, Xinru; Li, Borui; Cai, Zhenzhen; Chen, Shuwen; Hu, Jiahong; Yuan, Xuenan; Yang, Jie; Guo, An-Yuan; Zhang, Zhihong

Hypothermic machine perfusion protects DCD graft liver from ischemia‑reperfusion injury by enhancing macrophage efferocytosis via KLF2‑NLRP3 signaling.

低温机械灌注通过 KLF2-NLRP3 信号通路增强巨噬细胞吞噬作用,从而保护 DCD 移植肝脏免受缺血再灌注损伤。

KLF2 controls thymic epithelial cell homeostasis, impacting regulatory T cell development and immune tolerance.

KLF2 控制胸腺上皮细胞稳态,影响调节性 T 细胞发育和免疫耐受。

Ferreirinha Pedro, Rodrigues Pedro M, Sobral Francisco, Cavadas Bruno, Alves Nuno L

Krüppel-like Factor 2 (KLF2) Inducing Agents and Their Therapeutic Applications

Krüppel样因子2 (KLF2) 诱导剂及其治疗应用

Meng, Lingxin; Liang, Steven H

Krüppel-like Factor 2 (KLF2) in the Regulation of Lipid Accumulation, ROS, and Mitochondrial Functions During Foam Cell Formation in RAW264.7 Cells.

Krüppel 样因子 2 (KLF2) 在 RAW264.7 细胞泡沫细胞形成过程中对脂质积累、ROS 和线粒体功能的调节。

Howlader Md Sariful Islam, Das Manjusri, Hansda Surajit, Naidu Prathyusha, Das Hiranmoy

Transient loss of KLF2 expression is essential for CD8 effector T cell expansion

KLF2表达的短暂丧失对于CD8效应T细胞的扩增至关重要

Kansas, Geoffrey S

Hydroa Vacciniforme Lymphoproliferative Disorder With a Truncating KLF2 Variant Presenting as Benign Photodermatoses

伴有截断型 KLF2 变异的疫苗样水肿淋巴增生性疾病表现为良性光敏性皮肤病

Warner-Levy, John; Ong, Angelia; Farquharson, Nina; Ayer, Jean

KLF2 inhibits keloid progression by targeting PI3K/AKT-mediated MMP-2/9 signaling.

KLF2 通过靶向 PI3K/AKT 介导的 MMP-2/9 信号通路来抑制瘢痕疙瘩的进展。

Yu Dan, Zhao AoLin, Wang ZhiGuo